Main Line Fertility & Reproductive Medicine

Bryn Mawr, Pennsylvania 19010

Medical Director: Michael J. Glassner, MD

Main Line Fertility & Reproductive Medicine, located in Bryn Mawr, Pennsylvania, offers comprehensive fertility care under the leadership of Medical Director Dr. Michael J. Glassner, MD. The clinic provides a full range of services including IVF, egg freezing, donor egg programs, and surrogacy support to help you build your family. With their verified lab accreditation, you can trust that your care meets the highest standards.

Understanding success rates can bring clarity during this journey. For patients under 35, Main Line Fertility achieves a 38.70% live birth rate, while patients ages 35-37 see a 31.60% live birth rate. The clinic's experience shows in their volume—they completed 2,296 treatment cycles in 2022 alone, reflecting their commitment to serving the community's fertility needs. When you're feeling overwhelmed by options and statistics, Main Line Fertility focuses on providing personalized care tailored to your unique situation, helping you navigate this important chapter with both expertise and understanding.

Services Offered

IVF

In vitro fertilization — eggs are retrieved and fertilized in a lab, then transferred to the uterus.

Egg Freezing

Oocyte cryopreservation — eggs are retrieved and frozen for future use.

Donor Egg

Uses eggs from a screened donor for patients who cannot use their own.

Surrogacy

Gestational carrier arrangements — an embryo is transferred to a surrogate who carries the pregnancy.

Success Rates

Success rates reflect live births per intended egg retrieval, as reported to the CDC for the 2022 reporting year. Rates vary based on individual patient factors.

Age GroupFresh TransfersFrozen TransfersNat'l Avg
Under 3538.70%-9.747.90%48.4%
35–3731.60%-4.442.00%36%
38–4020.60%-3.037.50%23.6%
Over 407.30%-2.228.20%9.5%

Based on 2,296 total cycles reported. National averages computed across all reporting clinics.

Physicians

Nearby Clinics

Data on this page is sourced from the CDC's National ART Surveillance System (NASS) and the Society for Assisted Reproductive Technology (SART). Success rates reflect live births per intended egg retrieval for the 2022 reporting year. Individual results vary based on patient age, diagnosis, and treatment protocol.